This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Regional Universitaire De Brest, Centre National De La Recherche Scientifique, Institut Curie. Active years: 2022.
Company Filing History:
1 out of 1 
1 out of 5,383 
1 out of 161 
Years Active: 2022
Title: Oksana Reznichenko: Innovator in Cancer Treatment
Introduction
Oksana Reznichenko is a notable inventor based in Saint-Rémy-lès-Chevreuse, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. Her work focuses on addressing cancers associated with the Epstein-Barr Virus (EBV).
Latest Patents
Oksana holds a patent for "Hydrazone derivatives for preventing or treating EBV-related cancers." This invention relates to bis-hydrazone derivatives of a specific formula, which are designed to be effective in treating or preventing cancers linked to EBV. The patent outlines the chemical structure and potential applications of these compounds, emphasizing their utility as drugs.
Career Highlights
Throughout her career, Oksana has worked with prestigious institutions, including the Université de Bretagne Occidentale and the Université de Paris. Her research has contributed to advancements in the understanding and treatment of viral-related cancers.
Collaborations
Oksana has collaborated with esteemed colleagues such as Marc Blondel and Chrysoula Daskalogianni. These partnerships have enhanced her research efforts and broadened the impact of her work in the scientific community.
Conclusion
Oksana Reznichenko's innovative contributions to cancer treatment highlight her dedication to advancing medical science. Her patent on hydrazone derivatives represents a significant step forward in the fight against EBV-related cancers.